2016
DOI: 10.4251/wjgo.v8.i7.550
|View full text |Cite
|
Sign up to set email alerts
|

Management of colorectal neoplasia during pregnancy and in the postpartum period

Abstract: AIM:To report our experience on management of colorectal neoplasia during pregnancy and in the postpartum period. METHODS:Patients who were diagnosed with colorectal cancer during pregnancy or in the postpartum period (< 6 mo), between 8/1997 and 4/2013, in our department were reviewed. Patient characteristics, operations, fetal health and follow-up during pregnancy, type of delivery and oncologic outcomes were analyzed. RESULTS:Eight patients met our study criteria. Median age at the time of diagnosis of colo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
19
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(21 citation statements)
references
References 19 publications
2
19
0
Order By: Relevance
“…There have been similar recent reports by Kocian et al 10 (41 cases), Aytec et al 11 (eight cases), and Pellino et al 8 (119 cases). We have summarized these similarities in Table 2.…”
Section: Discussionsupporting
confidence: 84%
See 2 more Smart Citations
“…There have been similar recent reports by Kocian et al 10 (41 cases), Aytec et al 11 (eight cases), and Pellino et al 8 (119 cases). We have summarized these similarities in Table 2.…”
Section: Discussionsupporting
confidence: 84%
“…In the metastatic setting, there are 19 CRC antineoplastic agents approved for use. Some of these agents have been used in pregnancy and are described in case reports or series, however the majority have no information regarding pregnancy 8,1011,14–33. Long-term outcomes of infants exposed to these cytotoxic agents are unknown.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Possible complications include fetal growth restriction and premature delivery. When the condition permits, most researchers recommend postpartum chemotherapy (9,10). For advanced and metastatic CRC, FOLFOX [oxaliplatin, leucovorin, and 5-fluorouracil (5-FU)] regimen chemotherapy is recommended..…”
Section: Discussionmentioning
confidence: 99%
“…An opion would be the weekly therapy, especially the treatment with doxorubicin, paclitaxel, epirubicin, with minimal hematological effects in the mother and a much faster recovery for childbirth [225,226]. Chemotherapy should not be given after 33 weeks or 3 weeks before birth [227].…”
Section: Treatmentmentioning
confidence: 99%